Glenmede Trust CO Na Vericel Corp Transaction History
Glenmede Trust CO Na
- $20.6 Billion
- Q3 2024
A detailed history of Glenmede Trust CO Na transactions in Vericel Corp stock. As of the latest transaction made, Glenmede Trust CO Na holds 11,363 shares of VCEL stock, worth $599,284. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,363
Previous 11,255
0.96%
Holding current value
$599,284
Previous $516,000
6.98%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VCEL
# of Institutions
275Shares Held
48.7MCall Options Held
85.9KPut Options Held
23.2K-
Black Rock Inc. New York, NY8.06MShares$425 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$202 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$184 Million0.0% of portfolio
-
State Street Corp Boston, MA2.43MShares$128 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$125 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.49B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...